The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
Open accessAbstract
Genetic alterations in tumor cells often lead to the emergence of growth-stimulatory autocrine and paracrine signals, involving overexpression of secreted peptide growth factors, cytokines, and hormones. Increased levels of these soluble proteins may be exploited for cancer diagnosis and management or as points of therapeutic intervention. Here, we combined the use of controlled vocabulary terms and sequence-based algorithms to predict genes encoding secreted proteins from among approximately 12,500 sequences represented on oligonucleotide microarrays. Expression of these genes was queried in 150 carcinomas from 10 anatomic sites of origin and compared with 46 normal tissues derived from the corresponding sites of tumor origin and other body tissues and organs. Of 74 different genes identified as overexpressed in cancer tissues, several encode proteins with demonstrated clinical diagnostic application, such as alpha-fetoprotein in liver carcinoma, and kallikreins 6 and 10 in ovarian cancer, or therapeutic utility, such as gastrin-releasing peptide/bombesin in lung carcinomas. We show that several of the other candidate genes encode proteins with high levels of tumor-associated expression by immunohistochemistry on tissue microarrays and further demonstrate significantly elevated levels of another novel candidate protein, macrophage inhibitory cytokine 1, a distant member of the transforming growth factor-beta superfamily, in the serum of patients with metastatic prostate, breast, and colorectal carcinomas. Our results suggest that the combination of annotation/protein sequence analysis, transcript profiling, immunohistochemistry, and immunoassay is a powerful approach for delineating candidate biomarkers with potential clinical significance and may be broadly applicable to other human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated levels of GDF15 have been linked to tumor growth and poor prognosis in cancer patients raising the question as to whether GDF15 serves as a tumor suppressor or promoter and a target for the treatment of cancer (84, 85, 99).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
A new method for predicting signal sequence cleavage sites
von HEIJNE, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.11.4683 · Cited by 4,473
Bhattacharjee, A., Richards, W. G., Staunton, J. E., Li, C., Monti, S., Vasa, P. P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,558
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
Autocrine growth factors and cancer
Sporn, M. B., & Roberts, A. B. (1985) · Nature · doi:10.1038/313745a0 · Cited by 1,425
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180
RefSeq and LocusLink: NCBI gene-centered resources
Pruitt, K. D. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.137 · Cited by 884
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 851
Research works printed but not linked: 7
- P Buckhaults, C Rago, B St. Croix, K E Romans, S Saha, L Zhang, B Vogelstein, K W Kinzler Cancer Res 61, 6996–7001 (2001).
- J B Welsh, L M Sapinoso, A I Su, S G Kern, J Wang-Rodriguez, C A Moskaluk, H F Frierson, G M Hampton Cancer Res 61, 5974–5978 (2001).
- A I Su, J B Welsh, L M Sapinoso, S G Kern, P Dimitrov, H Lapp, P G Schultz, S M Powell, C A Moskaluk, H F Frierson, G M Hampton Cancer Res 61, 7388–7393 (2001).
- M S Lockhart, C Waldner, C Mongini, M J Gravisaco, S Casanova, E Alvarez, S Hajos Oncol Rep 6, 1129–1133 (1999).
- A G Moore, D A Brown, W D Fairlie, A R Bauskin, P K Brown, M L Munier, P K Russell, L A Salamonsen, E M Wallace, S N Breit J Clin Endocrinol Metab 85, 4781–4788 (2000).
- K J Martin, B M Kritzman, L M Price, B Koh, C P Kwan, X Zhang, A Mackay, M J O'Hare, C M Kaelin, G L Mutter, et al. Cancer Res 60, 2232–2238 (2000).
- W Zhou, L J Sokoll, D J Bruzek, L Zhang, V E Velculescu, S B Goldin, R H Hruban, S E Kern, S R Hamilton, D W Chan, et al. Cancer Epidemiol Biomarkers Prev 7, 109–112 (1998).
Cited by
Sorted by citations
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
The emerging roles of human tissue kallikreins in cancer
Borgoño, C. A., & Diamandis, E. P. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1474 · Cited by 661
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool
Diamandis, E. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400007-mcp200 · Cited by 634
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W.-W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1677 · Cited by 612
Self-citationDrapkin, R., von Horsten, H. H., Lin, Y., Mok, S. C., Crum, C. P., Welch, W. R., & Hecht, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3924 · Cited by 573
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Patel, S., Alvarez-Guaita, A., Melvin, A., Rimmington, D., Dattilo, A., Miedzybrodzka, E. L., Cimino, I., Maurin, A.-C., Roberts, G. P., Meek, C. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.016 · Cited by 509
Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
Talantov, D., Mazumder, A., Yu, J. X., Briggs, T., Jiang, Y., Backus, J., Atkins, D., & Wang, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0683 · Cited by 522
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Wischhusen, J., Melero, I., & Fridman, W. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00951 · Cited by 506
Adela, R., & Banerjee, S. K. (2015) · Journal of Diabetes Research · doi:10.1155/2015/490842 · Cited by 474
Li, F., Long, H., Zhou, Z.-W., Luo, H., Xu, S., & Gao, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910292 · Cited by 476
Tsai, V. W.-W., Husaini, Y., Sainsbury, A., Brown, D. A., & Breit, S. N. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.018 · Cited by 424
Justice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
Significance, detection and markers of disseminated breast cancer cells
Lacroix, M. (2006) · Endocrine Related Cancer · doi:10.1677/erc-06-0001 · Cited by 295
Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality
Wiklund, F. E., Bennet, A. M., Magnusson, P. K. E., Eriksson, U. K., Lindmark, F., Wu, L., Yaghoutyfam, N., Marquis, C. P., Stattin, P. E., Pedersen, N. L., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00629.x · Cited by 293
Koopmann, J., Zhang, Z., White, N., Rosenzweig, J. M., Fedarko, N. S., Jagannath, S. B., Canto, M. I., Yeo, C. J., Chan, D. W., & Goggins, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1167-3 · Cited by 277
Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278
Kozak, K. R., Amneus, M. W., Pusey, S. M., Su, F., Luong, M., Luong, S. A., Reddy, S. T., & Farias‐Eisner, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2033602100 · Cited by 271
Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers
Koopmann, J., Buckhaults, P., Brown, D. A., ZAHURAK, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0165 · Cited by 274
Unsicker, K., Spittau, B., & KRIEGLSTEIN, K. G. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.003 · Cited by 279
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
Bauskin, A. R., Brown, D. A., Kuffner, T., Johnen, H., Luo, X. W., Hunter, M., & Breit, S. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4067 · Cited by 251
Self-citationDaniels, L. B., Clopton, P., Laughlin, G. A., Maisel, A. S., & Barrett-Connor, E. L. (2011) · Circulation · doi:10.1161/circulationaha.110.979740 · Cited by 246
Breit, S. N., Johnen, H., Cook, A. D., Tsai, V. W. W., Mohammad, M. G., Kuffner, T., Zhang, H. P., Marquis, C. P., Jiang, L., Lockwood, G., et al. (2011) · Growth Factors · doi:10.3109/08977194.2011.607137 · Cited by 247
SELEX methods on the road to protein targeting with nucleic acid aptamers
Bayat, P., Nosrati, R., Alibolandi, M., Rafatpanah, H., Abnous, K., Khedri, M., & Ramezani, M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.09.001 · Cited by 246
Interplay of transcriptomics and proteomics
Hegde, P. S., White, I. R., & Debouck, C. M. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.006 · Cited by 230
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Breit, S. N., Brown, D. A., & Tsai, V. W.-W. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022020-045449 · Cited by 237
A role for microfluidic systems in precision medicine
Ayuso, J. M., Virumbrales-Muñoz, M., Lang, J. M., & Beebe, D. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30384-7 · Cited by 219
Li, S., Ma, Y., Zheng, P., & Zhang, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0744-0 · Cited by 214
Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry
Luque-Garcia, J. L., & Neubert, T. A. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.11.054 · Cited by 212
Koopmann, J., Rosenzweig, C. N., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M. I., Yeo, C. J., Chan, D. W., Breit, S. N., & Goggins, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0564 · Cited by 212
Mimeault, M., & Batra, S. K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22196 · Cited by 211
Qin, L., & Tang, Z. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0572-9 · Cited by 203
Roeßler, M., Rollinger, W., Palme, S., Hagmann, M., Berndt, P., Engel, A. M., Schneidinger, B., Pfeffer, M., Andres, H. H., Karl, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0983 · Cited by 197
A Hot New Twist to Hair Biology
Bodó, E., Bı́ró, T., Telek, A., Czifra, G., Griger, Z., Tóth, B. I., Mescalchin, A., Ito, T., Bettermann, A., Kovács, L., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62320-6 · Cited by 193
Ding, Q., Mráček, T., González‐Muniesa, P., Kos, K., Wilding, J. P. H., Trayhurn, P., & Chen, B. (2008) · Endocrinology · doi:10.1210/en.2008-0952 · Cited by 200
Molecular markers of prostate cancer outcome
Quinn, D. I., Henshall, S. M., & Sutherland, R. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.035 · Cited by 189
GDF15, an emerging key player in human aging
Conte, M., Giuliani, C., Chiariello, A., Iannuzzi, V., Franceschi, C., & Salvioli, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101569 · Cited by 202
TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator
Tsai, V. W.-W., Macia, L., Johnen, H., Kuffner, T., Manadhar, R., Jørgensen, S. B., Lee-Ng, K. K. M., Zhang, H. P., Wu, L., Marquis, C. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055174 · Cited by 188
Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: Revisiting old hypotheses
Fleming, J. S., Beaugié, C. R., Haviv, I., Chenevix‐Trench, G., & Tan, O. L. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.09.014 · Cited by 191
Human tissue kallikreins: The cancer biomarker family
Paliouras, M., Borgoño, C. A., & Diamandis, E. P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.018 · Cited by 186
Multiclass cancer classification and biomarker discovery using GA-based algorithms
Liu, J. J., Cutler, G., Li, W., Pan, Z., Peng, S., Hoey, T. C., Chen, L., & Ling, X. B. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti419 · Cited by 180
Wang, P., Mariman, E. C. M., Keijer, J., Bouwman, F. G., Noben, J., Robben, J., & Renes, J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4256-z · Cited by 182
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia
Siddiqui, J. A., Pothuraju, R., Κhan, P., Sharma, G., Muniyan, S., Seshacharyulu, P., Jain, M., Nasser, M. W., & Batra, S. K. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.11.002 · Cited by 187
GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas
Roth, P., Junker, M., Tritschler, I., Mittelbronn, M. G. A., Dombrowski, Y., Breit, S. N., Tabatabai, G., Wick, W., Weller, M., & Wischhusen, J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0705 · Cited by 177
Liu, T., Bauskin, A. R., Zaunders, J. J., Brown, D. A., Pankhurst, S., Russell, P. J., Breit, S. N., & Panhurst, S. (2003) · PubMed · Cited by 174
The cancer secretome: a reservoir of biomarkers
Xue, H., Lü, B., & Lai, M. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-52 · Cited by 170
How Industry Is Approaching the Search for New Diagnostic Markers and Biomarkers
Zolg, J. W., & Langen, H. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400007-mcp200 · Cited by 171
Emmerson, P. J., Duffin, K. L., Chintharlapalli, S. R., & Wu, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01712 · Cited by 178
Mattox, A. K., Douville, C. B., Wang, Y., Popoli, M., Ptak, J., Silliman, N., Dobbyn, L., Schaefer, J., Lu, S., Pearlman, A. H., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1252 · Cited by 174
Carbon nanotube-based ultrasensitive multiplexing electrochemical immunosensor for cancer biomarkers
Wan, Y., Deng, W., Su, Y. L., Zhu, X., Peng, C., Hu, H., Peng, H., Song, S., & Fan, C. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.08.033 · Cited by 162
Theodorescu, D., Sapinoso, L. M., Conaway, M. R., Oxford, G., Hampton, G. M., & Frierson, H. F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0653 · Cited by 161
Chan, S. K., Griffith, O. L., Tai, I. T., & Jones, S. J. M. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2615 · Cited by 159
The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer
Wang, X., Baek, S. J., & Eling, T. E. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.025 · Cited by 154
Bauskin, A. R., Brown, D. A., Junankar, S. R., Rasiah, K., Eggleton, S. A., Hunter, M. I., Liu, T., Smith, D., Kuffner, T., Pankhurst, G. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3827 · Cited by 154
Cryptophane Xenon-129 Nuclear Magnetic Resonance Biosensors Targeting Human Carbonic Anhydrase
Chambers, J. M., Hill, P. A., Himmelberger, J. A., Han, Z., Christianson, D. W., Kuzma, N. N., & Dmochowski, I. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja806092w · Cited by 151
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
Kulasingam, V., Pavlou, M. P., & Diamandis, E. P. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2831 · Cited by 150
Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer
Brown, D. A., Lindmark, F., Stattin, P. E., Bälter, K. A., Adami, H., Zheng, S. L., Xu, J., Isaacs, W. B., Grönberg, H., Breit, S. N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3126 · Cited by 152
Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery
Chen, R., Pan, S., Brentnall, T. A., & Aebersold, R. H. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500004-mcp200 · Cited by 152
Growth differentiation factor 15 in erythroid health and disease
Tanno, T., Noel, P., & Miller, J. L. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328337b52f · Cited by 139
Amin, A. R. M. R., Karpowicz, P. A., Carey, T. E., Arbiser, J. L., Nahta, R., Chen, Z. G., Dong, J., Küçük, Ö., Khan, G. N., Huang, G. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.005 · Cited by 146
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Melero, I., Luken, M. D. M., de Velasco, G., Garralda, E., Martín-Liberal, J., Joerger, M., Alonso, G., Goebeler, M.-E., Schüler, M., König, D., et al. (2024) · Nature · doi:10.1038/s41586-024-08305-z · Cited by 144
Human tissue kallikrein gene family: applications in cancer
Obiezu, C. V., & Diamandis, E. P. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.09.024 · Cited by 135
Guo, Y., Ayers, J. L., Carter, K. T., Wang, T., Maden, S. K., Edmond, D., Newcomb P, P., Li, C., Ulrich, C., Yu, M., et al. (2019) · Aging Cell · doi:10.1111/acel.13013 · Cited by 139
GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
Wallentin, L. C., Zethelius, B., Berglund, L., Eggers, K. M., Lind, L., Lindahl, B., Wollert, K. C., & Siegbahn, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078797 · Cited by 132
Kim, K. H., Kim, S., Han, D. H., Jo, Y. S., Lee, Y., & Lee, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25098-0 · Cited by 130
Wagner, K. W., Sapinoso, L. M., El-Rifai, W. M., Frierson, H. F., Butz, N., Mestan, J., Hofmann, F., Deveraux, Q. L., & Hampton, G. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207861 · Cited by 131
GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases
Fujita, Y., Ito, M., Kojima, T., Yatsuga, S., Koga, Y., & Tanaka, M. (2015) · Mitochondrion · doi:10.1016/j.mito.2014.10.006 · Cited by 128
Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15
Bruzzese, F., Hägglöf, C., Leone, A., Sjöberg, E., Roca, M. S., Kiflemariam, S., Sjöblom, T., Hammarsten, P., Egevad, L., Bergh, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2259 · Cited by 127
Bassil, C. F., Zhao, Y., Zavaglia, K. M., Jin, P., Panelli, M. C., Voiculescu, S. E., Mandruzzato, S., Lee, H. M., Seliger, B., Freedman, R. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3433 · Cited by 127
Ma, Y., Visser, L., Roelofsen, H., de Vries, M., Diepstra, A., Imhoff, G. W. V., van der Wal, T., Luinge, M. A., Álvarez‐Llamas, G., Vos, H. J., et al. (2007) · Blood · doi:10.1182/blood-2007-09-112128 · Cited by 127
Kallikreins – The melting pot of activity and function
Kalińska, M., Meyer‐Hoffert, U., Kantyka, T., & Potempa, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.023 · Cited by 131
Wang, Y., Chen, C., Chen, J., Sang, T., Peng, H., Lin, X., Zhao, Q., Chen, S., Eling, T. E., & Wang, X. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102322 · Cited by 130
Tsai, V. W.-W., Manandhar, R., Jørgensen, S. B., Lee-Ng, K. K. M., Zhang, H. P., Marquis, C. P., Jiang, L., Husaini, Y., Lin, S., Sainsbury, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100370 · Cited by 129
Hockley, S. L., Arlt, V. M., Brewer, D. S., Giddings, I., & Phillips, D. H. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-260 · Cited by 131
Boulay, A., Breuleux, M., Stephan, C., Fux, C., Brisken, C., Fiche, M., Wartmann, M., Stumm, M., Lane, H. A., & Hynes, N. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5100 · Cited by 123
Barderas, R., Mendes, M. L., Torres, S., Bartolomé, R. A., López-Lucendo, M. F., Villar-Vázquez, R., Peláez‐García, A., Fuente, E., Bonilla, F., & Casal, J. I. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.022848 · Cited by 126
Secretory cargo sorting at the trans-Golgi network
Kienzle, C., & von Blume, J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.007 · Cited by 125
Senapati, S., Rachagani, S., Chaudhary, K. R., Johansson, S. L., Singh, R. K., & Batra, S. K. (2009) · Oncogene · doi:10.1038/onc.2009.420 · Cited by 123
H6D Polymorphism in Macrophage-Inhibitory Cytokine-1 Gene Associated With Prostate Cancer
Lindmark, F., Zheng, S. L., Wiklund, F. E., Bensen, J. T., Bälter, K. A., Chang, B., Hedelin, M., Clark, J., Stattin, P., Meyers, D. A., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh227 · Cited by 120
Microfluidic systems for cancer diagnostics
Garcia-Cordero, J. L., & Maerkl, S. J. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.11.022 · Cited by 120
Patel, M. S., Lee, J. Y., Baz, M., Wells, C. E., Bloch, S. A. A., Lewis, A., Donaldson, A. V. J., Garfield, B. E., Hopkinson, N. S., Natanek, S. A., et al. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12096 · Cited by 116
Kim, K.-K., Lee, J. J., Yang, Y. D., You, K., & Lee, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn031 · Cited by 119
Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer
Staff, A. C., Bock, A. J., Becker, C., Kempf, T., Wollert, K. C., & Davidson, B. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.05.032 · Cited by 115
Mitochondrial stress and mitokines in aging
Burtscher, J., Soltany, A., Visavadiya, N. P., Burtscher, M., Millet, G. P., Khoramipour, K., & Khamoui, A. V. (2023) · Aging Cell · doi:10.1111/acel.13770 · Cited by 123
Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations
Diamandis, E. P., & van der Merwe, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.963.11.3 · Cited by 111
Makawita, S., Smith, C. R., Batruch, I., Zheng, Y., Rückert, F., Grützmann, R., Pilarsky, C. P., Gallinger, S., & Diamandis, E. P. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008599 · Cited by 113
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
Wallin, U., Glimelius, B. L. G., Jirström, K., Darmanis, S., Nong, R. Y., Pontén, F., Johansson, C., Påhlman, L., & Birgisson, H. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.112 · Cited by 111
Loumaye, A., & Thissen, J. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.07.011 · Cited by 112
Wang, X., Li, Y., Tian, H.-M., Qi, J., Li, M., Fu, C., Wu, F., Wang, Y., Cheng, D., Zhao, W., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-578 · Cited by 111
GDF 15 - A Novel Biomarker in the Offing for Heart Failure
George, M., Jena, A., Srivatsan, V., Rajaram, M., & Dhandapani, V. E. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160111125304 · Cited by 109
Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer
Kawanishi, H., Matsui, Y., Ito, M., Watanabe, J., Takahashi, T., Nishizawa, K., Nishiyama, H., Kamoto, T., Mikami, Y., Tanaka, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1922 · Cited by 109
Brown, D. A., Stephan, C., Ward, R. L., Law, M. G., Hunter, M., Bauskin, A. R., Amin, J., Jung, K., Diamandis, E. P., Hampton, G. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1331 · Cited by 109
Tsai, V. W.-W., Lin, S., Brown, D. A., Salis, A., & Breit, S. N. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.242 · Cited by 109
Boyle, G. M., Pedley, J., Martyn, A. C., Banducci, K., Strutton, G., Brown, D. A., Breit, S. N., & Parsons, P. G. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.270 · Cited by 109
Wang, W., Yang, X. N., Dai, J., Lü, Y., Zhang, J., & Keller, E. T. (2019) · Oncogene · doi:10.1038/s41388-019-0736-3 · Cited by 109
Pharmacogenomic Identification of Novel Determinants of Response to Chemotherapy in Colon Cancer
Boyer, J. D., Allen, W. L., McLean, E. G., Wilson, P. M., McCulla, A., Moore, S., Longley, D. B., Caldas, C., & Johnston, P. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2693 · Cited by 106
Catalytic Deoxyribozyme-Modified Nanoparticles for RNAi-Independent Gene Regulation
Yehl, K. M., Joshi, J. P., Greene, B. L., Dyer, R. B., Nahta, R., & Salaita, K. S. (2012) · ACS Nano · doi:10.1021/nn3034265 · Cited by 104
Corre, J., Labat, E., Espagnolle, N., Hébraud, B., Avet‐Loiseau, H., Roussel, M., Huynh, A., Gadelorge, M., Cordelier, P., Klein, B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0188 · Cited by 106
GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
Borner, T., Wald, H. S., Ghidewon, M. Y., Zhang, B., Wu, Z., Jonghe, B. C. D., Breen, D. M., & Grill, H. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107543 · Cited by 101
Haake, M., Haack, B., Schäfer, T., Harter, P. N., Mattavelli, G., Eiring, P., Vashist, N., Wedekink, F., Genßler, S., Fischer, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39817-3 · Cited by 116
Endothelin Axis Is a Target of the Lung Metastasis Suppressor Gene RhoGDI2
Titus, B. J., Frierson, H. F., Conaway, M. R., Ching, K., Guise, T. A., Chirgwin, J. M., Hampton, G. M., & Theodorescu, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1403 · Cited by 102
Metadata
- Authors
- Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., Sutherland, R. L., Breit, S. N., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M.
- Affiliations
- Genomics Institute of the Novartis Research Foundation (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-03-06
- Volume
- 100
- Issue
- 6
- Pages
- 3410-3415
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC152306
- OpenAlex
- W2155470210
- Cited by
- 503
- References
- 38
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 30 · 2023: 24 · 2022: 22 · 2021: 22 · 2020: 28 · 2019: 15 · 2018: 17 · 2017: 21 · 2016: 14 · 2015: 18 · 2014: 21 · 2013: 22 · 2012: 29
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- secreted proteins, tumor markers, gene overexpression, oligonucleotide microarrays, gene expression profiling, cytokines, growth factors, alpha-fetoprotein, kallikrein, gastrin-releasing peptide, MIC-1, TGF-beta superfamily, serum biomarkers, metastatic carcinoma, cancer diagnosis
- MeSH terms
- Female, Humans, Male, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Biomarkers, Tumor, Cytokines, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Databases, Genetic, Growth Differentiation Factor 15
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review